Bayer AG

BAYN

DE000BAY0017

Pharmaceuticals

Market Closed - Xetra Other stock markets 16:37:35 11/09/2024 BST			5-day change	1st Jan Change
27.01 ^EUR	-2.19%		-2.88%	-19.68%

09-11	Bayer to present results from AMD trials	CF
09-11	Agrochemicals group Syngenta cuts jobs in Basel	RE

BAYER AG : UBS sticks Neutral

August 02, 2024 at 10:20 am

Initially Neutral on the company, UBS's analyst Jo Walton maintained his recommendation. The target price is unchanged at EUR 32.

Latest news about Bayer AG

Bayer to present results from AMD trials	09-11	CF
Agrochemicals group Syngenta cuts jobs in Basel	09-11	RE
Bayer falls in recovered market environment - glyphosate remains in focus	09-11	DP
Bayer wants to take glyphosate lawsuits to the highest US court	09-11	RE
Goldman rates Bayer at 'Neutral' - Target 30 euros	09-10	DP
BAYER AG : Goldman Sachs remains Neutral	09-10	ZD
Study: Agriculture could significantly reduce greenhouse gases	09-10	DP
Bayer's Finerenone Cuts Risk of New-onset Diabetes in Late-stage Trial	09-10	MT
Bayer's OcuClick Secures Approval from European Medicines Agency	09-09	MT
BAYER AG : UBS sticks Neutral	09-09	ZD
Bayer: receives EMA approval	09-09	CF
Bayer: last-minute presentations at ESMO congress	09-06	CF
Veeva Systems: leader in cloud solutions for the life sciences industry	09-06
Bayer's bottoming out continues to take shape - BofA commentary	09-06	DP
Bayer gains significantly - focus on US glyphosate dispute	09-05	DP
Bayer: new data for menopause treatment	09-05	CF
Bayer: will present new data at ESMO	09-05	CF
WDH: Fewer crop protection products planned for fields	09-04	DP
Bayer to Unveil New Data from its Phase III OASIS 3 Long-Term Study of Elinzanetant in the Treatment of Vasomotor Symptoms Associated with Menopause	09-04	CI
Expert dialog recommends restructuring EU agricultural policy	09-04	DP
Transcript : Bayer Aktiengesellschaft Presents at Barclays 17th Annual Global Consumer Staples Conference, Sep-03-2024 04:29 PM	09-03
Bayer: FDA approval for investigational drug	09-03	CF
US will still pay at least twice as much after negotiating drug prices	09-03	RE
Transcript : Bayer Aktiengesellschaft - Special Call	09-02
Bayer: positive study on finerenone in cardiology	09-02	CF

Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.5%). Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).

Employees

96,567

Sector

Pharmaceuticals

Calendar

05/11/2024 - Q3 2024 Earnings Release

Related indices

Euro STOXX 50 Index , STOXX Europe 600 Index (EUR) , DAX

More about the company